US 10995150
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody
granted A61KA61K2039/505A61K31/4015
Quick answer
US patent 10995150 (Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K31/4015, A61K39/3955, A61P